Brexpiprazole

Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic. It is a dopamine D2 recepto...

Brexpiprazole

Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic. It is a dopamine D2 receptor partial agonist and has been ... ,This medication is used to treat certain mental/mood disorders (such as schizophrenia, depression). Brexpiprazole helps you to think more clearly, feel less ...

相關軟體 Brave Browser 資訊

Brave Browser
新的 Brave 瀏覽器會自動阻止廣告和跟踪器,使其比當前瀏覽器更快,更安全。除了真實的內容,一切頁面的加載速度都是驚人的。最多 60%的網頁加載時間是由每次在您最喜歡的新聞網站上打開頁面時加載到各個位置的基礎廣告技術引起的。而這 20%是花費在加載正在嘗試了解更多關於你的東西上的時間. 選擇版本:Brave Browser 0.19.123 Dev(32 位)Brave Browser 0.19... Brave Browser 軟體介紹

Brexpiprazole 相關參考資料
Brexpiprazole - PubMed

由 M Markovic 著作 · 2017 · 被引用 11 次 — Brexpiprazole showed efficacy for the treatment of schizophrenia in the range of 2 to 4 mg/d and as an adjunct to antidepressant therapy in MDD when dosed at&nb...

https://pubmed.ncbi.nlm.nih.go

Brexpiprazole - Wikipedia

Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic. It is a dopamine D2 receptor partial agonist and has been ...

https://en.wikipedia.org

Brexpiprazole Oral : Uses, Side Effects, Interactions, Pictures ...

This medication is used to treat certain mental/mood disorders (such as schizophrenia, depression). Brexpiprazole helps you to think more clearly, feel less ...

https://www.webmd.com

Brexpiprazole | C25H27N3O2S - PubChem

Brexpiprazole is an atypical antipsychotic used in the treatment of schizophrenia and major depressive disorders. · Brexpiprazole is a N-arylpiperazine.

https://pubchem.ncbi.nlm.nih.g

Brexpiprazole: A Review in Schizophrenia - PubMed

由 JE Frampton 著作 · 2019 · 被引用 13 次 — Abstract. Brexpiprazole (Rxulti®, Rexulti®) is an oral atypical antipsychotic agent approved for the treatment of schizophrenia in the EU ...

https://pubmed.ncbi.nlm.nih.go

Brexpiprazole: A review of a new treatment option for ...

由 LA Diefenderfer 著作 · 2017 · 被引用 19 次 — Brexpiprazole (Rexulti®, Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan) is an atypical antipsychotic that was approved by the US Food and Drug ...

https://www.ncbi.nlm.nih.gov

Brexpiprazole: so far so good - NCBI - NIH

由 S Das 著作 · 2016 · 被引用 38 次 — Brexpiprazole has antipsychotic-like activity and robust efficacy in relevant models of cognitive impairment associated with schizophrenia. It also has inhibitory&nb...

https://www.ncbi.nlm.nih.gov

新藥介紹-Brexpiprazole (Rexulti®)

思覺失調症(Schizophrenia)在台灣2014. 年以前稱之為「精神分裂症」,病人通常. 伴隨慢性及反覆的精神症狀,症狀為語言. 混亂、行為異常,出現妄想、幻聽、 ...

https://www.skh.org.tw

銳思定膜衣錠(Rexulti tablets) 醫療科技評估報告 - 衛生福利部 ...

▫ Brexpiprazole 治療的藥物計畫成本(drug plan cost)不應超. 過最低成本之非典型抗精神病製劑之藥物計畫成本。 PBAC(澳洲). 澳洲PBAC 於民國106 年03 月 ...

https://www.nhi.gov.tw